GlassScriptPhysician profile
Heidi G Miller
NPI 1831506682
$102,071.98
in general payments reported to CMS, 2019-2025
14 companies · $8,735 in 2025
The $8,735 reported for 2025 was more than what 99% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28K · 2020: $9,453 · 2021: $34K · 2022: $13K · 2023: $3,210 · 2024: $5,483 · 2025: $8,735.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,425 · Food and Beverage: $3,853 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,800 · Travel and Lodging: $1,152 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,425.00 |
| Food and Beverage | $3,852.52 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,800.00 |
| Travel and Lodging | $1,151.82 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $59,563.82 | 2019-2025 | Total30, Dailies Total1, Precision7 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $20,471.79 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $10,919.49 | 2022-2025 | Zenlens, Alden Scleral Zenlens |
| Valley Contax, INC. | $5,864.73 | 2019-2022 | |
| Johnson & Johnson Vision Care, INC. | $1,826.01 | 2019-2025 | Acuvue |
| Alcon Research LLC | $1,575.00 | 2022 | |
| Coopervision INC. | $455.27 | 2021-2025 | Misight Contact Lens, Ortho-K Contact Lens, Onefit Contact Lens |
| Tarsus Pharmaceuticals, INC. | $420.07 | 2024-2025 | Xdemvy |
| Dompe US, INC. | $371.97 | 2023-2025 | Oxervate |
| Sun Pharmaceutical Industries INC. | $173.89 | 2019-2021 | |
| Harrow Eye, LLC | $138.15 | 2025 | Vevye |
| Sight Sciences, INC. | $126.61 | 2019 | |
| Oyster Point Pharma, INC. | $122.74 | 2023 | Tyrvaya |
| Visioneering Technologies, INC. | $42.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heidi Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.